EP3684336A4 - Verfahren und zusammensetzungen zur behandlung von epidermolysis bullosa - Google Patents
Verfahren und zusammensetzungen zur behandlung von epidermolysis bullosa Download PDFInfo
- Publication number
- EP3684336A4 EP3684336A4 EP18859166.3A EP18859166A EP3684336A4 EP 3684336 A4 EP3684336 A4 EP 3684336A4 EP 18859166 A EP18859166 A EP 18859166A EP 3684336 A4 EP3684336 A4 EP 3684336A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- compositions
- treatment
- methods
- epidermolysis bullosa
- bullosa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010014989 Epidermolysis bullosa Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Physical Water Treatments (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/712,294 US20180104186A1 (en) | 2013-03-13 | 2017-09-22 | Methods and compositions for the treatment of epidermolysis bullosa |
PCT/US2018/052213 WO2019060719A1 (en) | 2017-09-22 | 2018-09-21 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF BULLETIN EPIDERMOLYSIS |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3684336A1 EP3684336A1 (de) | 2020-07-29 |
EP3684336A4 true EP3684336A4 (de) | 2021-06-02 |
Family
ID=65810503
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP18859166.3A Pending EP3684336A4 (de) | 2017-09-22 | 2018-09-21 | Verfahren und zusammensetzungen zur behandlung von epidermolysis bullosa |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP3684336A4 (de) |
JP (1) | JP7525396B2 (de) |
KR (1) | KR20200088799A (de) |
CN (1) | CN111182890A (de) |
AU (1) | AU2018335788B2 (de) |
CA (1) | CA3076610A1 (de) |
EA (1) | EA202090814A1 (de) |
IL (1) | IL273407A (de) |
MX (2) | MX2020002777A (de) |
WO (1) | WO2019060719A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10640464B2 (en) | 2011-01-03 | 2020-05-05 | The William M. Yarbrough Foundation | Use of isothiocyanate functional surfactants as Nrf2 inducers to treat epidermolysis bullosa simplex and related diseases |
KR102125567B1 (ko) * | 2019-07-02 | 2020-06-22 | 한양대학교 에리카산학협력단 | 식물 엑소좀의 대량 생산 방법 |
AU2020459825A1 (en) * | 2020-07-22 | 2023-03-16 | Osaka University | Therapeutic agent for dystrophic epidermolysis bullosa |
MX2023001927A (es) * | 2020-08-21 | 2023-03-09 | Univ Miami | Composiciones y metodos de tratamiento usando microvesiculas de celulas madre mesenquimaticas derivadas de medula osea. |
EP3971440B1 (de) | 2020-09-21 | 2023-12-27 | Brembo S.p.A. | Bremsband einer scheibenbremsscheibe sowie scheibenbremsscheibe |
WO2023018891A1 (en) * | 2021-08-12 | 2023-02-16 | Onconova Therapeutics, Inc. | Methods and compositions for treating cancer |
EP4415732A1 (de) * | 2021-10-12 | 2024-08-21 | Eliksa Therapeutics, Inc. | Verfahren zur behandlung von epidermolysis bullosa mit zellfreien amnionflüssigkeitszusammensetzungen |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015138878A1 (en) * | 2014-03-13 | 2015-09-17 | Research Institute At Nationwide Children's Hospital, Inc. | Methods of delivering heparin binding epidermal growth factor using stem cell generated exosomes |
WO2017123022A1 (ko) * | 2016-01-12 | 2017-07-20 | 주식회사 강스템바이오텍 | 고함량의 성장인자를 함유한 줄기세포 유래 엑소좀 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT2972193T (pt) * | 2013-03-13 | 2020-04-23 | Univ Miami | Método para isolamento e purificação de microvesículas de sobrenadantes de cultura celular e fluidos biológicos |
WO2015038075A1 (en) | 2013-09-16 | 2015-03-19 | Agency For Science, Technology And Research | Method |
WO2016172598A1 (en) * | 2015-04-22 | 2016-10-27 | The Broad Institute Inc. | Exosomes and uses thereof |
WO2017122095A1 (en) * | 2016-01-15 | 2017-07-20 | Orbsen Therapeutics Limited | Sdc-2 exosome compositions and methods of isolation and use |
-
2018
- 2018-09-21 EP EP18859166.3A patent/EP3684336A4/de active Pending
- 2018-09-21 CA CA3076610A patent/CA3076610A1/en active Pending
- 2018-09-21 KR KR1020207010214A patent/KR20200088799A/ko not_active Application Discontinuation
- 2018-09-21 WO PCT/US2018/052213 patent/WO2019060719A1/en unknown
- 2018-09-21 AU AU2018335788A patent/AU2018335788B2/en active Active
- 2018-09-21 MX MX2020002777A patent/MX2020002777A/es unknown
- 2018-09-21 CN CN201880061329.5A patent/CN111182890A/zh active Pending
- 2018-09-21 EA EA202090814A patent/EA202090814A1/ru unknown
- 2018-09-21 JP JP2020516903A patent/JP7525396B2/ja active Active
-
2020
- 2020-03-12 MX MX2022015753A patent/MX2022015753A/es unknown
- 2020-03-18 IL IL273407A patent/IL273407A/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015138878A1 (en) * | 2014-03-13 | 2015-09-17 | Research Institute At Nationwide Children's Hospital, Inc. | Methods of delivering heparin binding epidermal growth factor using stem cell generated exosomes |
WO2017123022A1 (ko) * | 2016-01-12 | 2017-07-20 | 주식회사 강스템바이오텍 | 고함량의 성장인자를 함유한 줄기세포 유래 엑소좀 |
US20190133922A1 (en) * | 2016-01-12 | 2019-05-09 | Kangstem Biotech Co., Ltd. | Stem Cell-Derived Exosomes Containing a High Amount of Growth Factors |
Non-Patent Citations (2)
Title |
---|
DINH HA ET AL: "Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges", ACTA PHARMACEUTICA SINICA B, vol. 6, no. 4, 1 July 2016 (2016-07-01), pages 287 - 296, XP055303644, ISSN: 2211-3835, DOI: 10.1016/j.apsb.2016.02.001 * |
See also references of WO2019060719A1 * |
Also Published As
Publication number | Publication date |
---|---|
CA3076610A1 (en) | 2019-03-28 |
EP3684336A1 (de) | 2020-07-29 |
EA202090814A1 (ru) | 2020-08-07 |
MX2020002777A (es) | 2020-09-17 |
AU2018335788A1 (en) | 2020-03-19 |
JP7525396B2 (ja) | 2024-07-30 |
WO2019060719A1 (en) | 2019-03-28 |
JP2020534344A (ja) | 2020-11-26 |
CN111182890A (zh) | 2020-05-19 |
KR20200088799A (ko) | 2020-07-23 |
MX2022015753A (es) | 2023-01-19 |
AU2018335788B2 (en) | 2024-08-15 |
IL273407A (en) | 2020-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3675882A4 (de) | Verfahren und zusammensetzungen zur behandlung von erkrankungen im zusammenhang mit mikrobiomen | |
EP3684336A4 (de) | Verfahren und zusammensetzungen zur behandlung von epidermolysis bullosa | |
EP3630072A4 (de) | Verfahren und zusammensetzungen zur behandlung von übermässiger schläfrigkeit | |
EP3607072A4 (de) | Zusammensetzungen und verfahren zur behandlung von phenylketonurie | |
EP3347469A4 (de) | Verfahren und zusammensetzungen zur behandlung von glaukom | |
EP3426250A4 (de) | Behandlungsverfahren | |
EP3373951A4 (de) | Verfahren und zusammensetzungen zur behandlung von epidermolysis bullosa | |
EP3602606A4 (de) | Verfahren zur oberflächenbehandlung und zusammensetzungen dafür | |
EP3408344A4 (de) | Verfahren und zusammensetzungen zur bohrlochbehandlung | |
EP3217795A4 (de) | Zusammensetzungen und verfahren zur behandlung mit prodrugs aus tizoxanid, einem analog oder salz davon | |
EP3585817A4 (de) | Zusammensetzungen und verfahren zur behandlung von krebs | |
EP3448421A4 (de) | Verfahren und zusammensetzungen zur vorbeugung und behandlung von chirurgischen verklebungen | |
EP3538189A4 (de) | Zusammensetzungen, vorrichtungen und verfahren zur behandlung von opioidrezeptorvermittelten zuständen | |
EP3720421A4 (de) | Zusammensetzungen und verfahren zur behandlung von stoffwechselkrankheiten | |
EP3634422A4 (de) | Verfahren zur behandlung von leukodystrophien | |
EP3429584A4 (de) | Zusammensetzungen und verfahren zur behandlung von presbyopie | |
EP3368048A4 (de) | Verfahren und zusammensetzungen zur behandlung von amyloidose | |
EP3310783A4 (de) | Verfahren und zusammensetzungen zur vorbeugung und behandlung von hörverlust | |
EP3643316A4 (de) | Behandlungsmittel für epidermolysis bullosa | |
EP3423064A4 (de) | Formulierungen von testosteron und verfahren zur behandlung damit | |
EP3452044A4 (de) | Zusammensetzungen und verfahren zur krebsbehandlung | |
EP3341006A4 (de) | Zusammensetzungen und verfahren zur behandlung von nervenschäden | |
EP3373922A4 (de) | Zusammensetzungen und verfahren zur behandlung von homocystinurie | |
EP3349719A4 (de) | Zusammensetzungen und verfahren zur behandlung und prävention von strahlendermatitis | |
EP3719032A4 (de) | Zusammensetzung zur vorbeugung oder behandlung von haarausfall |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20200422 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40031789 Country of ref document: HK |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20210506 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 9/127 20060101AFI20210429BHEP Ipc: A61K 35/28 20150101ALI20210429BHEP Ipc: A61Q 19/00 20060101ALI20210429BHEP Ipc: A61P 17/00 20060101ALI20210429BHEP |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230601 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |